Related Experiment Videos
SCC tumour marker and its relationship to clinical stage in squamous cervical cancer
R J Henry1, J K Dodd, J P Tyler
1Department of Obstetrics and Gynaecology, University of Sydney, Westmead Hospital, New South Wales.
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|November 1, 1987
Abstract:
Serum from 103 patients with histologically proven squamous cell cervical carcinoma were analysed for the presence of tumour marker, SCC antigen. Although values ranged between 0.2-109.7 ng/ml the majority of cases (75%) fell below 7.9 ng/ml. There was no relationship between SCC antigen values and clinical stage. The high false negative rate (29%) of this marker in patients with proven disease would preclude its use as a diagnostic screen.